Personalized whole genome sequencing approach could double the diagnostic rates of rare diseases

AI nuclear energy background, future innovation of disruptive technology

Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases, finds a new study led by UCL researchers.

DNA barcoding shows how cancer cells evade the immune system’s defenses

Previous article

Pioneering artificial intelligence could ease winter pressures on hospitals

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News